MarketsTrump Inks Order to Bring Down US Drug Prices, But Skips Details on Generics DrugsBY Vaibhavi Ranjan
MarketsEmcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% PremiumBY Outlook Business Desk